Industry

Global $10.8 Bn Self-injection Devices Market Trends/Analysis 2022-2030 by Product (Autoinjectors, Needle-free Injectors), Usability (Disposable, Reusable), Application (Cancer, Pain Management) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Self-injection Devices Market Size, Share & Trends Analysis Report by Product (Autoinjectors, Needle-free Injectors), by Usability (Disposable, Reusable), by Application (Cancer, Pain Management), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global self-injection devices market size is expected to reach USD 10.8 billion by 2030 and is … [Read more…]

Alpha Cognition Announces Successful Defense of European Patent Covering ALPHA-0602

VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announces that the European Patent Office has confirmed the patentability of EP3009143 in amended form following an opposition … [Read more…]

Medidata Leaders to Share Best Practices on Decentralized Trials, Patient Centricity, and Adaptive Trial Design at DIA Annual Meeting

NEW YORK–(BUSINESS WIRE)–#DCT—Medidata, a Dassault Systèmes company, will be leading an innovative educational workshop on how to master decentralized clinical trials (DCTs), sessions on risk-based monitoring and adaptive designs, and more as a premium sponsor of the DIA (Drug Information Association) Global Annual Meeting, June 19-23. Medidata experts will also be participating in multiple presentations … [Read more…]

Humana Healthy Horizons Commits $4.6 Million to Improve Health of Ohioans

Community investments benefit eight organizations throughout Ohio COLUMBUS, Ohio–(BUSINESS WIRE)–Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), announced today that it has invested $4.6 million to support community organizations in Ohio that share the company’s passion for overcoming public health challenges and improving the health and well-being … [Read more…]

MIT-Northpond Program Created to Advance Innovation in Engineering and Life Science

CAMBRIDGE, Mass.–(BUSINESS WIRE)–MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program – Advancing Life Science & Engineering Innovation. The five-year engagement is funded through Northpond Labs, the research and development-focused affiliate of Northpond Ventures. The program aims to generate ideas in the life sciences by connecting Northpond’s experienced venture … [Read more…]

Affini-T Therapeutics & Metagenomi Announce Next-Generation Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients

BOSTON & SEATTLE & EMERYVILLE, Calif.–(BUSINESS WIRE)–Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation, wholly-owned gene editing tools, today announced a partnership to enable Affini-T’s next generation ex vivo T cell receptor (TCR) cell … [Read more…]

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

WASHINGTON–(BUSINESS WIRE)–#alzheimers—The Women’s Brain Project, an international non-profit organization studying gender and sex determinants to brain and mental health and Altoida, a precision neurology company pioneering non-invasive brain health diagnostics using AI and augmented reality (AR), today announced results from a study showing sex-based differences using digital biomarker data collected from Altoida’s digital cognitive assessment … [Read more…]

Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer

WALTHAM, Mass.–(BUSINESS WIRE)–Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced the appointment of Adam Muzikant, PhD, as Chief Business Officer. Dr. Muzikant brings 18 years of business development experience creating and executing value-creating deals, from platform collaborations to commercial-stage product licenses and M&A, across a range of therapeutic areas and technologies … [Read more…]

Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, announced that the Company’s first-in-human Phase 1 clinical study initiated today with the dosing of a first subject with AST-004. The promising investigational therapeutic, AST-004, is being advanced as a potential acute treatment for stroke … [Read more…]

Walgreens and Greater Than AIDS Partner with Health Departments and Community Organizations to Provide Free HIV Testing and Information in More Than 250 Cities on National HIV Testing Day (June 27)

Largest Coordinated HIV Testing Event in the Nation DEERFIELD, Ill. & SAN FRANCISCO–(BUSINESS WIRE)–Walgreens and Greater Than AIDS, a public information initiative of KFF (Kaiser Family Foundation), are teaming up with health departments and community organizations in more than 250 cities to host the largest coordinated National HIV Testing Day (NHTD) event in the nation. … [Read more…]